Crystal structure of Plasmodium falciparum dihydroorotate dehydrogenase bound with Inhibitor DSM778 (3-methyl-N-(1-(5-methyl-1H-pyrazol-3-yl)ethyl)-4-(1-(6-(trifluoromethyl)pyridin-3-yl)cyclopropyl)-1H-pyrrole-2-carboxamide)
收藏Protein Data Bank Japan2023-10-18 更新2026-03-21 收录
下载链接：
https://pdbj.org/mine/summary/7kzy
下载链接
链接失效反馈官方服务：
资源简介：
Crystal structure of Plasmodium falciparum dihydroorotate dehydrogenase bound with Inhibitor DSM778 (3-methyl-N-(1-(5-methyl-1H-pyrazol-3-yl)ethyl)-4-(1-(6-(trifluoromethyl)pyridin-3-yl)cyclopropyl)-1H-pyrrole-2-carboxamide) Descriptor: 3-methyl-N-[(1R)-1-(5-methyl-1H-pyrazol-3-yl)ethyl]-4-{1-[6-(trifluoromethyl)pyridin-3-yl]cyclopropyl}-1H-pyrrole-2-carboxamide, Dihydroorotate dehydrogenase (quinone), mitochondrial, ... Authors: Deng, X, Phillips, M, Tomchick, D. Deposit date: 2020-12-10 Release date: 2021-05-19 Last modified: 2023-10-18 Method: X-RAY DIFFRACTION (1.75 Å) Cite: Potent Antimalarials with Development Potential Identified by Structure-Guided Computational Optimization of a Pyrrole-Based Dihydroorotate Dehydrogenase Inhibitor Series. J.Med.Chem., 64, 2021
恶性疟原虫（Plasmodium falciparum）二氢乳清酸脱氢酶（dihydroorotate dehydrogenase）与抑制剂DSM778（3-甲基-N-(1-(5-甲基-1H-吡唑-3-基)乙基)-4-(1-(6-(三氟甲基)吡啶-3-基)环丙基)-1H-吡咯-2-甲酰胺）结合的晶体结构
描述符：3-甲基-N-[(1R)-1-(5-甲基-1H-吡唑-3-基)乙基]-4-{1-[6-(三氟甲基)吡啶-3-基]环丙基}-1H-吡咯-2-甲酰胺，线粒体二氢乳清酸脱氢酶（醌类），……
作者：邓X、菲利普斯M、汤姆奇克D
提交日期：2020-12-10
发布日期：2021-05-19
最后修改日期：2023-10-18
检测方法：X射线衍射（1.75 Å）
引用文献：《通过基于吡咯类二氢乳清酸脱氢酶抑制剂系列的结构导向计算优化发现具有开发潜力的强效抗疟药物》，J.Med.Chem.，64卷，2021年
创建时间：
2020-12-10
